This announcement is a separate document:
麗珠醫藥:持續關連交易 與麗珠單抗訂立新二零二三採購框架協議
LIVZON PHARMA: CONTINUING CONNECTED TRANSACTIONS ENTERING INTO THE NEW 2023 PURCHASE FRAMEWORK AGREEMENT WITH LIVZON MAB
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.